Jeffrey S. Heier - 18 Jun 2021 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Director
Signature
/s/ Donald Notman, Attorney-in-Fact for Jeffrey S. Heier
Issuer symbol
OCUL
Transactions as of
18 Jun 2021
Transactions value $
$0
Form type
4
Filing time
22 Jun 2021, 20:00:43 UTC
Next filing
16 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUL Stock Option (Right to Buy) Award $0 +18,000 $0 18,000 18 Jun 2021 Common Stock 18,000 $13.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests with respect to 100% of the securities on the first anniversary of the grant date.